Peanut

Generic Name
Peanut
Brand Names
Palforzia 12 Mg (level 3), Palforzia 120 Mg (level 7), Palforzia 160 Mg (level 8), Palforzia 20 Mg (level 4), Palforzia 200 Mg (level 9), Palforzia 240 Mg (level 10), Palforzia 3 Mg (level 1), Palforzia 300 Mg (level 11), Palforzia 40 Mg (level 5), Palforzia 6 Mg (level 2), Palforzia 80 Mg (level 6), Palforzia Initial Dose Escalation
Drug Type
Biotech
Chemical Formula
-
CAS Number
-
Unique Ingredient Identifier
QE1QX6B99R
Background

Peanut allergenic extract is used in allergenic testing.

Associated Conditions
-
Associated Therapies
-
healio.com
·

Q&A: First patient dosed in IgGenix ACCELERATE Peanut phase 1 clinical trial

IgGenix announced the first patient dosed with IGNX001, a monoclonal antibody therapeutic for peanut allergy, in the ACCELERATE Peanut phase 1 clinical trial. The trial aims to assess safety, tolerability, and proof of mechanism in patients aged 15 years and older. IGNX001 attaches to peanut proteins to neutralize them, differing from other immunotherapies like Palforzia and Xolair. The trial is ongoing in Australia, with recruitment targeting older adolescents and adults, and initial results expected mid-2025.
© Copyright 2024. All Rights Reserved by MedPath